DealoDigest
SPAC Mergers

Merger Announcement: Crown PropTech Sets Nov. 25 Vote on Mkango Deal

Crown PropTech Acquisitions filed its definitive proxy for a Nov. 25 shareholder vote on a merger that would list Mkango Rare Earths on Nasdaq under MKAR.

Nov 4, 20263 min read
3min read
1sources
3topics
Nov 4published
Rare earth mineral samples on a laboratory table
Rare earth mineral samples on a laboratory table. Image: James St. John via wikimedia (CC BY 2.0)

Crown PropTech Acquisitions (CPTK), a Cayman Islands special purpose acquisition company, filed its definitive merger proxy on Nov. 4 and called an extraordinary general meeting for Nov. 25 to vote on a combination with Mkango Rare Earths Limited. The merger announcement moves a deal first disclosed in July 2025 into its final stretch.

Key takeaways

  • Shareholders vote at 10:00 a.m. Eastern on Nov. 25 at Crown’s offices at 40 West 57th Street in New York; the record date was Oct. 30.
  • Redemption requests and share delivery are due by 5:00 p.m. Eastern on Nov. 23.
  • Mkango Rare Earths expects to list on Nasdaq as MKAR, with warrants as MKARW; the listing is subject to Nasdaq approval and is a closing condition.
  • The business combination agreement dates to July 2, 2025 and was amended twice before being amended and restated on Sept. 2, 2026.

How the deal works

A Mkango subsidiary, Mkango (Cayman) Limited, will merge into Crown, which survives as a wholly owned subsidiary of Mkango Rare Earths. Mkango Rare Earths, the parent that filed the registration statement on Form F-4, would become the publicly traded company. Its parent, Mkango Magnetic Materials Limited, which is listed on AIM and the TSX Venture Exchange, would hold about 78.7% of the pro forma shares if no one redeems, or 39,856,079 of 50,646,694.

Mkango Rare Earths would hold the Songwe Hill project in Malawi and the Pulawy project in Poland. The proxy defines equity value as $400 million, adjusted for the company’s debt and cash at closing and for transaction expenses above a cap. The proxy statement/prospectus is dated Nov. 4 and was expected to be first mailed to shareholders on or about Nov. 5.

The terms at a glance

ItemDetail
VoteNov. 25, 2026, 10:00 a.m. ET
Redemption deadlineNov. 23, 2026, 5:00 p.m. ET
Trust value per shareAbout $12.05 (Aug. 31, 2026)
Public Class A shares outstanding483,822 on the record date
Anticipated PIPE$23.0 million
Net tangible assets floor$5,000,001
Crown’s business combination deadlineMarch 11, 2027

What shareholders are voting on

Crown holders are asked to approve the business combination as an ordinary resolution and the merger as a special resolution. The proxy also puts advisory governance proposals on authorized share capital and the appointment and removal of directors, an equity incentive plan, and an adjournment proposal.

The size of the float stands out. With only 483,822 public Class A shares left against 6.9 million Class B shares, redemptions can take little from the trust. In the maximum-redemption case the proxy describes, 83,822 shares redeem for about $1.0 million and $4.8 million stays in trust. The PIPE then matters more: it is anticipated at $23.0 million, and about $9.2 million of it would be needed in that scenario.

Points the proxy flags for holders

The risk factors are blunt about dilution. The Class B shares were bought at a nominal price, so public holders who stay through closing face immediate and substantial dilution. Redemptions above 15% of public shares need Crown’s consent. The new company would be a controlled company, given Mkango Magnetic Materials’ stake. The sponsor, CIIG Management III LLC, and Crown’s officers and directors would lose their entire investment in Crown if no deal closes.

What to watch

The calendar is short: redemption deadline Nov. 23, vote Nov. 25. The gating items are the vote, Nasdaq’s approval of the MKAR listing and the minimum cash condition. If any slips, Crown’s March 11, 2027 deadline to complete a business combination is the backstop.

Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.

Related